Endothelial cell autoantibodies are a marker of disease susceptibility in inflammatory bowel disease but apparently not linked to persistent measles virus infection

Clinical Immunology

Volumn 95, Issue 3, 2000, Pages 197-202

  Folwaczny, C ^a   Loeschke, K ^a   Schnettler, D ^a   Jager G ^a   Wiebecke, B ^a   Hoelscher, M ^a   Sauer, T ^b   Konig A ^a   Endres, S P ^a   Fricke, H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Bayerisches Rotes Kreuz   (Germany)

Author keywords

Endothelial cell autoantibodies; Inflammatory bowel disease; Measles virus

Indexed keywords

AUTOANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; ENTERITIS; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEASLES; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ULCERATIVE COLITIS; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION;

EID: 0034120443     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4867     Document Type: Article

References (50)

1. Mayer L. H. J. Extraintestinal manifestations of inflammatory bowel disease. Kirsner J. B., Shorter R. G. Inflammatory Bowel Disease. 1988;299-317 Lea and Febiger, New York.
2. Knox R. L., Schachart A. P., Mustonsen E. Primary secondary and coincidental ocular complications of Crohn's disease. Ophthalmology. 91:1984;163-173.
3. Yasinger S. Association of inflammatory bowel disease and large vascular lesions. Gastroenterology. 71:1979;844A.
4. Wakefield A. J., Sawyerr A. M., Dhillon A. P. Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet. 2:1989;1057-1062.
5. Knutson H., Lunderquist A. Vascular changes in Crohn's disease. Am. J. Roentgenol. 103:1968;380-385.
6. Geller S. A., Cohen A. Arterial inflammatory infiltration in Crohn's disease. Arch. Pathol. Lab. Med. 107:1983;473.
7. Sisbigee B., Rottenberg D. A. Sagittal sinus thrombosis as a complication of regional enteritis. Ann. Neurol. 3:1978;470-475.
8. Koenigs K. P., McPhedran P., Spiro H. M. Thrombosis in inflammatory bowel disease. J. Clin. Gastroenterol. 9:1987;627-631.
9. Folwaczny C., Wiebecke B., Loeschke K. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am. J. Gastroenterol. 94:1999;1551-1555.
10. Folwaczny C., Spannagl M., Wiebecke B. Heparin in the treatment of highly active inflammatory bowel disease (IBD). Gastroenterology. 110:1996;A908.
11. Gaffney P. R., O Leary J. I., Doyle C. T. Response to heparin in patients with ulcerative colitis. Lancet. 337:1991;238-239.
12. Gaffney P. R., Doyle C. T., Gaffney A. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am. J. Gastroenterol. 90:1995;220-223.
13. Gaffney P. R., Gaffney A. Heparin therapy in refractory ulcerative colitis - An update. Gastroenterology. 110:1996;A913.
14. Evans R. C., Rhodes J. M. Heparin, used i.v. and with sulphasalazine, appears to be effective in the treatment of refractory U.C., and warrants larger controlled trials. Gut. 37:1995;A49.
15. Schürmann G. M., Bishop A. E., Facer P. Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut. 36:1995;411-418.
16. Yang, H., Vora, D. K., Targan, S. R.et al.,Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology109, 440-448, 1995.
17. Jones S. C., Banks R. E., Haidar A. Adhesion molecules in inflammatory bowel disease. Gut. 36:1995;724-730.
18. Wakefield A. J., Pittilo R. M., Sim R. Evidence of persistent measles virus infection in Crohn's disease. J. Med. Virol. 39:1993;345-353.
19. Wakefield A. J., Ekbom A., Dhillon A. P. Crohn's disease: Pathogenesis and persistent measles virus infection. Gastroenterology. 108:1995;911-916.
20. Miyamoto H., Tanaka T., Kitamoto N. Detection of immunoreactive antigen with a monoclonal antibody to measles virus, in tissue from a patient with Crohn's disease. J. Gastroenterol. 30:1995;28-33.
21. Wakefield A. J., Sim R., Akbar A. N. In situ immune responses in Crohn's disease: A comparison with acute and persistent measles virus infection. J. Med. Virol. 51:1997;90-100.
22. Daszak P., Purcell M., Lewin J. Detection and comparative analysis of persistent measles virus infection in Crohn's disease by immunogold electron microscopy. J. Clin. Pathol. 50:1997;299-304.
23. Lewin J., Dhillon A. P., Sim R. Persistent measles virus infection of the intestine: Confirmation by immunogold electron microscopy. Gut. 36:1995;564-569.
24. Thompson S. P., Montgomery S. M., Pounder R. E. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet. 345:1995;1071-1074.
25. Leung D. Y. M., Collins T., Lapierre L. A. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J. Clin. Invest. 77:1986;1428-1435.
26. Tannenbaum S. H., Finko R., Cines D. B. Antibody and immune complexes induce tissue factor production by human endothelial cells. J. Immunol. 137:1986;1532-1537.
27. Stevens T. R. J., Harley S. L., Groom J. S. Anti-endothelial cell antibodies in inflammatory bowel disease. Dig. Dis. Sci. 38:1993;426-432.
28. Sawyer A. M., Pottinger B. E., Savage C. O. Serum immunoglobulin G reactive with endothelial cells in inflammatory bowel disease. Dig. Dis. Sci. 39:1994;1909-1917.
29. Aldebert D., Masy E., Reaumaux D. Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease. Dig. Dis. Sci. 42:1997;2350-2355.
30. Shanahan F., Duerr R. H., Rotter J. I. Neutrophil autoantibodies in ulcerative colitis: Familial aggregation and genetic heterogeneity. Gastroenterology. 103:1992;456-461.
31. Seibold F., Slametschka D., Gregor M. Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 107:1994;532-536.
32. Folwaczny C., Noehl N., Endres S. P. Anti-goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterology. 113:1997;101-106.
33. Fiocchi C., Roche J. K., Michener W. M. High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. Ann. Intern. Med. 110:1989;786-794.
34. Folwaczny C., Noehl N., Endres S. P. Antinuclear autoantibodies in patients with inflammatory bowel disease: High prevalence in first-degree relatives. Dig. Dis. Sci. 42:1997;1593-1597.
35. Shanahan F. Antibody "markers" in Crohn's disease: Opportunity or overstatement? Gut. 40:1998;557-558.
36. Müller-Ladner U., Schölmerich J. Pancreatic autoantibodies in Crohn's disease. Eur. J. Clin. Invest. 29:1999;46-47.
37. Macpherson A., Khoo U. Y., Forgacs I. Mucosal autoantibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut. 38:1996;365-375.
38. Targan S. R., Landers C. J., Cobb L. Perinuclear anti-neutrophil cytoplasmatic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. J. Immunol. 155:1995;3262-3267.
39. Lindquist R. J., Osterland C. K. Human antibodies to vascular epithelium. Clin. Exp. Immunol. 9:1971;753-760.
40. Romas E., Paspaliaris B., d'Apice A. J. Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease. Aust. N. Z. J. Med. 22:1992;652-659.
41. Lam A., Borda I. T., Inwood M. J. Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology. 68:1975;245-251.
42. Sankey E. A., Dhillon A. P., Anthony A. Early mucosal changes in Crohn's disease. Gut. 34:1993;375-381.
43. Hudson M., Hutton R. A., Wakefield A. J. Evidence for activation of coagulation in Crohn's disease. Blood Coagul. Fibrinolysis. 3:1992;773-778.
44. Collins, C. E., and Rampton, D. S., Platelets in inflammatory bowel disease-pathogenetic role and therapeutic implications. Aliment. Pharmacol. Ther.11, 237-247, 1997. [Review article].
45. Thompson N. P., Wakefield A. J., Pounder R. E. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology. 108:1995;1011-1015.
46. Lewin J., Dhillon A. P., Sim R. Persistent measles virus infection of the intestine: Confirmation by immunogold electron microscopy. Gut. 36:1995;564-569.
47. Montgomery S. M., Morris D. L., Pounder R. E. Paramyxovirus infections in the childhood and subsequent inflammatory bowel disease. Gastroenterology. 116:1999;796-803.
48. Ter Meulen V. Measles virus and Crohn's disease: View of a medical virologist. Gut. 43:1998;733-734.
49. Haga Y., Funakoshi O., Kuroe K. Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polmerase chain reaction. Gut. 38:1996;211-215.
50. Iizuka M., Nakagomi O., Chiba M. Absence of measles virus in Crohn's disease. Lancet. 345:1995;199.